乐心医疗(300562) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 273,307,188.91, representing a 9.90% increase compared to CNY 248,679,459.90 in the same period last year[9] - Net profit attributable to shareholders was CNY 22,942,005.96, a significant increase of 67.88% from CNY 13,665,579.08 year-on-year[9] - Basic earnings per share increased by 83.33% to CNY 0.11 from CNY 0.06 in the same period last year[9] - Operating profit for the current period was ¥24,057,675.80, up 73.5% from ¥13,909,787.94 in the previous period[29] - Net profit attributable to the parent company was ¥22,942,005.96, representing a 67.9% increase from ¥13,665,579.08 in the previous period[29] - The company reported a total comprehensive income of ¥22,785,354.31, significantly higher than ¥12,754,666.03 in the previous period[29] Cash Flow - The net cash flow from operating activities reached CNY 28,502,113.99, a remarkable improvement of 274.60% compared to a negative cash flow of CNY -16,324,596.58 in the previous year[9] - Operating cash inflow for the current period was $266,392,771.71, an increase of 8.4% from $246,127,581.32 in the previous period[32] - Cash outflow from investment activities totaled $562,271,853.44, up from $509,400,306.34 in the previous period, resulting in a net cash outflow of $371,564,941.99[32] - Cash flow from financing activities showed a net outflow of $1,025,367.97, compared to a larger outflow of $8,998,181.40 in the previous period[33] - The cash and cash equivalents at the end of the period amounted to $384,707,513.04, an increase from $299,245,956.61 in the previous period[33] - The company paid $739,653.67 in dividends and interest, compared to $238,380.40 in the previous period, indicating an increase in cash distribution[33] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,539,493,256.22, up 1.77% from CNY 1,512,766,953.89 at the end of the previous year[9] - Total liabilities rose slightly to ¥538,025,504.24 from ¥536,253,156.23, indicating a marginal increase of 0.3%[27] - The total equity attributable to the parent company increased to ¥1,021,282,764.47, up 2.2% from ¥996,172,799.98[27] Investments - The company reported a significant increase in trading financial assets, which rose by 187,527.93% to CNY 362,558,064.69 due to investments in bank wealth management products[14] - The company’s investment activities generated a net cash outflow of CNY -371,564,941.99, which was a 21.23% increase in outflow compared to CNY -306,496,499.41 in the previous year[16] - The company reported a 196.88% increase in fair value changes, amounting to CNY 1,306,601.23, attributed to the performance of bank wealth management products[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 26,159, with the largest shareholder holding 30.72% of the shares[17] - The total number of restricted shares decreased from 56,393,880 to 56,309,582, with 84,298 shares released during the period[22] - The company has a total of 1,100,000 shares under equity incentive restrictions, which will be released in two phases after 12 months[22] Other Financial Metrics - The weighted average return on equity improved to 2.27%, up from 1.30% in the same period last year[9] - Research and development expenses for the current period were ¥26,345,008.64, a decrease of 4.7% from ¥27,632,310.25 in the previous period[28] - The company's cash and cash equivalents decreased from CNY 764,004,671.27 to CNY 422,724,558.81, representing a decline of approximately 44.8%[25] - Accounts receivable increased from CNY 159,064,184.19 to CNY 198,933,476.03, reflecting a growth of about 25%[25] - Inventory decreased from CNY 96,190,264.83 to CNY 73,994,931.64, indicating a reduction of approximately 23%[25] - Total current assets increased slightly from CNY 1,046,554,028.30 to CNY 1,074,002,983.66, showing a growth of about 2.6%[25] - Long-term equity investments decreased from CNY 9,538,284.67 to CNY 8,469,064.18, a decline of approximately 11.2%[25] - The company's fixed assets decreased from CNY 216,274,280.86 to CNY 212,048,537.68, a reduction of about 1.9%[25]